CLIA: 39D2085645
New York State has a separate and unique regulatory approval process for laboratory diagnostic testing. PeriRx is currently in the application process with our SaliMark™ OSCC test and is vigorously committed to pursuing this application approval.
OSCC Salivary Test Now Available
Nearly 45,750 Americans will be diagnosed with oral or pharyngeal cancer this year, according to the Oral Cancer Foundation. In 5 years, only slightly more than half of those patients will still be alive. The high rate of mortality is due to late diagnosis of the disease, which typically isn’t noticed until it has reached stage III or IV.
PeriRx LCC hopes to change that with SaliMark OSCC, which clinicians can use to screen patients for oral squamous cell carcinoma (OSCC). The easy to use yet advanced molecular DNA salivary test is now available from the online ordering systems of Benco Dental, Henry Schein Dental, and Patterson Dental. [Read more…]